EA015250B9 - Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof - Google Patents
Tablets of sildenafil providing modified pharmaceutics and method for preparing thereofInfo
- Publication number
- EA015250B9 EA015250B9 EA201001679A EA201001679A EA015250B9 EA 015250 B9 EA015250 B9 EA 015250B9 EA 201001679 A EA201001679 A EA 201001679A EA 201001679 A EA201001679 A EA 201001679A EA 015250 B9 EA015250 B9 EA 015250B9
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- sildenafil
- pharmaceutics
- tablets
- preparing
- tablet
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to medicine, in particular to pharmaceutical industry and provides a tablet for the treatment of male erectile dysfunction comprising sildenafil or a pharmaceutically acceptable salt thereof as an active substance. The tablet also comprises hydroxypropylcellulose and colloid anhydrous silicon dioxide and film-coated. The invention also provides a method for manufacturing the tablet and use thereof for the treatment of male erectile dysfunction. According to the invention is characterized by modified pharmaceutics in case of single oral administration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201001679A EA015250B9 (en) | 2010-11-19 | 2010-11-19 | Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201001679A EA015250B9 (en) | 2010-11-19 | 2010-11-19 | Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
EA015250B1 EA015250B1 (en) | 2011-06-30 |
EA201001679A1 EA201001679A1 (en) | 2011-06-30 |
EA015250B9 true EA015250B9 (en) | 2013-10-30 |
Family
ID=44356420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001679A EA015250B9 (en) | 2010-11-19 | 2010-11-19 | Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA015250B9 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA004068B1 (en) * | 1998-10-23 | 2003-12-25 | Пфайзер Рисерч Энд Дивелопмент Компани Н.В./С.А. | Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
UA9883U (en) * | 2005-04-15 | 2005-10-17 | Pharcos Pharmaceutical Company | Tablet for treating erectile dysfunction |
BG108969A (en) * | 2004-12-08 | 2006-06-30 | "Софарма" Ад | Medicamentous form of sildenafil |
RU2285520C2 (en) * | 2002-02-07 | 2006-10-20 | Фармация Корпорейшн | Pharmaceutical dosed formulation for delivery through mucosa |
-
2010
- 2010-11-19 EA EA201001679A patent/EA015250B9/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA004068B1 (en) * | 1998-10-23 | 2003-12-25 | Пфайзер Рисерч Энд Дивелопмент Компани Н.В./С.А. | Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
RU2285520C2 (en) * | 2002-02-07 | 2006-10-20 | Фармация Корпорейшн | Pharmaceutical dosed formulation for delivery through mucosa |
BG108969A (en) * | 2004-12-08 | 2006-06-30 | "Софарма" Ад | Medicamentous form of sildenafil |
UA9883U (en) * | 2005-04-15 | 2005-10-17 | Pharcos Pharmaceutical Company | Tablet for treating erectile dysfunction |
Also Published As
Publication number | Publication date |
---|---|
EA015250B1 (en) | 2011-06-30 |
EA201001679A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ631100A (en) | Soft chewable pharmaceutical products | |
PH12014502271A1 (en) | Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same | |
WO2014027975A3 (en) | Novel orally administered pharmaceutical formulations | |
PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
NZ595467A (en) | Sublingual pharmaceutical composition comprising a neutral oil | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
MY157307A (en) | Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbersartan | |
MX2021001905A (en) | Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate. | |
PH12014501408A1 (en) | Immediate release multi unit pellet system | |
EA201391689A1 (en) | SYSTEM OF DELIVERY MEDICINE | |
MX2015009546A (en) | Increased dosage of efavirenz for the treatment of cancer. | |
MX341660B (en) | Ghrelin receptor agonist for treatment of dyscrasia. | |
JP2015521647A5 (en) | ||
EA015250B9 (en) | Tablets of sildenafil providing modified pharmaceutics and method for preparing thereof | |
WO2011108882A3 (en) | Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient | |
MX2017000384A (en) | Capsule dosage form of metoprolol succinate. | |
MX2014005960A (en) | Nitrogen-containing fused ring compounds for use as crth2 antagonists. | |
PH12016502540A1 (en) | Pharmaceutical dosage forms | |
IN2014CN02343A (en) | Oral formulations containing hyaluronic acid for sustained drug release | |
EA201691763A1 (en) | STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID | |
WO2013054178A3 (en) | Extended release pharmaceutical compositions containing carmabazepine | |
WO2013057569A3 (en) | Extended release pharmaceutical composition containing amoxicillin and clavulanic acid | |
UA97044C2 (en) | Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases | |
IN2013MU03389A (en) | ||
WO2014064711A3 (en) | Methods of administering raltegravir and raltegravir compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM MD TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KG TJ |
|
RH4A | Grant of a duplicate of a eurasian patent | ||
TH4A | Publication of the corrected specification to eurasian patent |